UniSource Energy Corp. (UNS) Tops Q2 EPS by 22c
Tweet
Share
E-mailGet Alerts UNS Hot Sheet
Join SI Premium – FREE
UniSource Energy Corp. (NYSE: UNS) reported Q2 EPS of $0.83, $0.22 better than the analyst estimate of $0.61. Revenue for the quarter came in at $365.2 million versus the consensus estimate of $365.7 million.
Our second quarter results mark the end of a four and a half year base rate freeze at TEP. The rate freeze, coupled with little to no economic growth, created significant challenges during this period," said Paul Bonavia, UNS Energy's Chairman and Chief Executive Officer. "Our employees responded by consistently controlling costs while improving safety and reliability."
In June, the Arizona Corporation Commission (ACC) approved new rates for TEP that became effective on July 1. The new rates include TEP's first base rate increase since 2008.
"TEP's new retail rates promote rate stability and strengthen TEP's financial position, bolstering our ability to make long-term investments that are in the best interests of our customers," Bonavia said.
For earnings history and earnings-related data on UniSource Energy Corp. (UNS) click here.
Our second quarter results mark the end of a four and a half year base rate freeze at TEP. The rate freeze, coupled with little to no economic growth, created significant challenges during this period," said Paul Bonavia, UNS Energy's Chairman and Chief Executive Officer. "Our employees responded by consistently controlling costs while improving safety and reliability."
In June, the Arizona Corporation Commission (ACC) approved new rates for TEP that became effective on July 1. The new rates include TEP's first base rate increase since 2008.
"TEP's new retail rates promote rate stability and strengthen TEP's financial position, bolstering our ability to make long-term investments that are in the best interests of our customers," Bonavia said.
For earnings history and earnings-related data on UniSource Energy Corp. (UNS) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Outlook Therapeutics (OTLK) Misses Q3 EPS by 9c
- Edible Garden AG (EDBL) Reports Q2 Loss of $18.79
- Calidi Biotherapeutics (CLDI) Reports Q2 Loss of $2.94
Create E-mail Alert Related Categories
Earnings, Management CommentsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
